HMGB3 and cervical carcinoma: Taken together, these data indicated that HMGB3 transcriptionally upregulated hTERT expression, and then activated DNA damage repairsignaling pathways, thereby promoting radioresistance and eventual poor outcomes in human cervical cancer (Fig. 6g).